Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes

D J Campbell1, M McGrady, D L Prior

  • 1St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia. dcampbell@svi.edu.au

Insights

Many adults on blood pressure medication don't reach target levels. Most receive only one or two drug classes, suggesting more medication and lifestyle changes could improve control in those at high cardiovascular risk.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Public Health

Background:

  • A significant number of patients on antihypertensive therapy do not achieve target blood pressure (<140/90 mmHg).
  • Understanding factors influencing blood pressure control is crucial for developing effective treatment strategies.
  • This study focuses on adults at increased cardiovascular risk.

Purpose of the Study:

  • To examine the association between blood pressure control and antihypertensive therapies.
  • To identify clinical and lifestyle factors associated with uncontrolled blood pressure.
  • To inform strategies for improving hypertension management in at-risk populations.

Main Methods:

  • A cross-sectional study of 3994 adults from the SCReening Evaluation of the Evolution of New Heart Failure (SCREEN-HF) study in Australia.
  • Inclusion criteria included age ≥60 years with cardiovascular risk factors or treated hypertension/diabetes.
  • Blood pressure control was assessed, and associations with therapies and factors were analyzed.

Main Results:

  • Of 3623 participants on antihypertensive therapy, 52% had blood pressure ≥140/90 mmHg.
  • The majority (79%) of those with uncontrolled blood pressure were on one or two antihypertensive drug classes.
  • Uncontrolled blood pressure was associated with older age, male sex, larger waist circumference, and higher NT-proBNP levels.

Conclusions:

  • Most individuals with treated hypertension above target are on limited antihypertensive drug classes.
  • Increasing the number of antihypertensive drug classes and incorporating lifestyle modifications may enhance blood pressure control.
  • These interventions could benefit individuals with increased cardiovascular risk.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Types of &#946;-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...